Nanotechnology

Self-polymerized platinum (II)-Polydopamine nanomedicines for photo-chemotherapy of bladder Cancer favoring antitumor immune responses | Journal of Nanobiotechnology


  • Barani M, Hosseinikhah SM, Rahdar A, Farhoudi L, Arshad R, Cucchiarini M, Pandey S. Nanatechnol Bladder Cancer: Diagnosis Treat Cancers. 2021;13(9):2214.

    CAS 
    PubMed 

    Google Scholar
     

  • Tran LD, Xiao JF, Agarwal N, Duex JE, Theodorescu D. Advances in bladder cancer biology and therapy. Nat Rev Cancer. 2021;21(2):104–21.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404–23.

    Article 
    PubMed 

    Google Scholar
     

  • Su HW, Jiang HT, Tao T, Kang X, Zhang X, Kang DY, Li SC, Li CX, Wang HF, Yang Z, et al. Hope and challenge: Precision medicine in bladder cancer. Cancer Med. 2019;8(4):1806–16.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nadal R, Bellmunt J. Management of metastatic bladder cancer. Cancer Treat Rev. 2019;76:10–21.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Pettenati C, Ingersoll MA. Mechanisms of BCG immunotherapy and its outlook for bladder cancer. Nature Reviews Urology 2018, 15:615–625. Nat. Rev. Urol. 2018, 15(10):615–625.

  • Afonso J, Santos LL, Longatto A, Baltazar F. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy. Nat Rev Urol. 2020;17(2):77–106.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jain P, Kathuria H, Momin M. Clinical therapies and nano drug delivery systems for urinary bladder cancer. Pharmacol Ther. 2021;226:107871.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Taarnhoj GA, Johansen C, Lindberg H, Basch E, Dueck A, Pappot H. Patient reported symptoms associated with quality of life during chemo- or immunotherapy for bladder cancer patients with advanced disease. Cancer Med. 2020;9(9):3078–87.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Taber A, Christensen E, Lamy P, Nordentoft I, Prip F, Lindskrog SV, Birkenkamp-Demtroder K, Okholm TLH, Knudsen M, Pedersen JS, et al. Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis. Nat Commun. 2020;11(1):4858.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jiang D, Gupta S, Kitchlu A, Meraz-Munoz A, North SA, Alimohamed NS, Blais N, Sridhar SS. Defining cisplatin eligibility in patients with muscle-invasive bladder cancer. Nat Rev Urol. 2021;18(2):104–14.

    Article 
    PubMed 

    Google Scholar
     

  • Seiler R, Gibb EA, Wang NQ, Oo HZ, Lam HM, van Kessel KE, Voskuilen CS, Winters B, Erho N, Takhar MM, et al. Divergent Biological response to Neoadjuvant Chemotherapy in muscle-invasive bladder Cancer. Clin Cancer Res. 2019;25(16):5082–93.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Burdett S, Fisher DJ, Vale CL, Tierney JF, Clarke NW, Parmar MKB, Sternberg CN, Stockle M, Lehmann J, Studer UE, et al. Adjuvant chemotherapy for muscle-invasive bladder Cancer: a systematic review and Meta-analysis of individual participant data from Randomised controlled trials. Eur Urol. 2022;81(1):50–61.

    Article 

    Google Scholar
     

  • Drayton RM, Catto JWF. Molecular mechanisms of cisplatin resistance in bladder cancer. Anticancer Ther. 2012;12(2):271–81.

    Article 
    CAS 

    Google Scholar
     

  • Long XB, Xiong W, Zeng XT, Qi L, Cai Y, Mo M, Jiang HC, Zhu BS, Chen Z, Li Y. Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ER beta/Bcl-2 signalling. Cell Death Discov. 2019;10(5):375.

    Article 

    Google Scholar
     

  • Su YJ, Yang WP, Jiang N, Shi JY, Chen LP, Zhong GZ, Bi JM, Dong W, Wang Q, Wang CH, Lin TX. Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance. Int J Biol Sci. 2019;15(2):441–52.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen FM, Zhang F, Wang YB, Peng JH, Cao L, Mei Q, Ge MF, Li L, Chen MW, Dong WF, Chang ZM. Biomimetic Redox-Responsive Mesoporous Organosilica Nanoparticles enhance cisplatin-based chemotherapy. Front Bioeng Biotech. 2022;10:860949.

    Article 

    Google Scholar
     

  • Chen FM, Zhang F, Shao D, Zhang WB, Zheng LQ, Wang W, Yang WD, Wang Z, Chen JX, Dong WF, et al. Bioreducible and traceable Ru(III) prodrug-loaded mesoporous silica nanoparticles for sequentially targeted nonsmall cell lung cancer chemotherapy. Appl Mater Today. 2020;19:100558.

    Article 

    Google Scholar
     

  • Zhao CY, Cheng R, Yang Z, Tian ZM. Nanotechnology for Cancer Therapy based on Chemotherapy. Molecules. 2018;23:826.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Song WT, Anselmo AC, Huang L. Nanotechnology intervention of the microbiome for cancer therapy. Nat Nanotechnol. 2019;14(12):1093–103.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Yang YJ, Chen FM, Xu N, Yao QC, Wang R, Xie XC, Zhang F, He Y, Shao D, Dong WF, et al. Red-light-triggered self-destructive mesoporous silica nanoparticles for cascade-amplifying chemo-photodynamic therapy favoring antitumor immune responses. Biomaterials. 2022;281:121368.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bilal M, Qindeel M, Raza A, Mehmood S, Rahdar A. Stimuli-responsive nanoliposomes as prospective nanocarriers for targeted drug delivery. J Drug Delivery Sci Technol. 2021;66:102916.

    Article 
    CAS 

    Google Scholar
     

  • Li DD, Zhang RH, Liu GT, Kang Y, Wu J. Redox-Responsive Self-Assembled nanoparticles for Cancer Therapy. Adv Healthc Mater. 2020;9(20):e2000605.

    Article 
    PubMed 

    Google Scholar
     

  • Peng J, Chen F, Liu Y, Zhang F, Cao L, You Q, Yang D, Chang Z, Ge M, Li L, et al. A light-driven dual-nanotransformer with deep tumor penetration for efficient chemo-immunotherapy. Theranostics. 2022;12(4):1756–68.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shao D, Zhang F, Chen F, Zheng X, Hu H, Yang C, Tu Z, Wang Z, Chang Z, Lu J, et al. Biomimetic Diselenide-Bridged Mesoporous Organosilica Nanoparticles as an x-ray-responsive biodegradable carrier for chemo-immunotherapy. Adv Mater. 2020;32(50):e2004385.

    Article 
    PubMed 

    Google Scholar
     

  • Han Y, Wen P, Li J, Kataoka K. Targeted nanomedicine in cisplatin-based cancer therapeutics. J Controlled Release. 2022;345:709–20.

    Article 
    CAS 

    Google Scholar
     

  • Wan XM, Beaudoin JJ, Vinod N, Min YZ, Makita N, Bludau H, Jordan R, Wang A, Sokolsky M, Kabanov AV. Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments. Biomaterials. 2019;192:1–14.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nseyo UO, DeHaven J, Dougherty TJ, Potter WR, Merrill DL, Lundahl SL, Lamm DL. Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long term experience. J Clin Laser Med Surg. 1998;16(1):61–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lin TS, Zhang Q, Yuan A, Wang BJ, Zhang FF, Ding YZ, Cao WM, Chen W, Guo HQ. Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for bladder Cancer Treatment. Theranostics. 2020;10:7683–96.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhou BQ, Liu JX, Lin MA, Zhu JY, Chen WR. Recent advances in immunotherapy, immunoadjuvant, and nanomaterial-based combination immunotherapy. Coord Chem Rev. 2021;442:214009.

    Article 
    CAS 

    Google Scholar
     

  • Railkar R, Agarwal PK. Photodynamic therapy in the treatment of bladder Cancer: Past Challenges and current innovations. Eur Urol Focus. 2018;4(4):509–11.

    Article 
    PubMed 

    Google Scholar
     

  • Emamzadeh M, Emamzadeh M, Pasparakis G. Dual controlled delivery of Gemcitabine and Cisplatin using polymer-modified thermosensitive liposomes for pancreatic Cancer. ACS Appl Bio Mater. 2019;2(3):1298–309.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gonzalez-Pastor R, Lancelot A, Morcuende-Ventura V, San Anselmo M, Sierra T, Serrano JL, Martin-Duque P. Combination chemotherapy with cisplatin and chloroquine: Effect of Encapsulation in Micelles formed by Self-Assembling Hybrid Dendritic-Linear-Dendritic Block Copolymers. Int J Mol Sci. 2021;22:5223.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang W, Jin Y, Xu Z, Liu X, Bajwa SZ, Khan WS, Yu H. Stimuli-activatable nanomedicines for chemodynamic therapy of cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12(4):e1614.

    Article 
    PubMed 

    Google Scholar
     

  • Shi SW, Li YH, Zhang QL, Yang SP, Liu JG. Targeted and NIR light-controlled delivery of nitric oxide combined with a platinum(iv) prodrug for enhanced anticancer therapy. J Mater Chem B. 2019;7(11):1867–74.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Chen G, Yang Y, Xu Q, Ling M, Lin H, Ma W, Sun R, Xu Y, Liu X, Li N, et al. Self-amplification of Tumor oxidative stress with degradable metallic complexes for synergistic Cascade Tumor Therapy. Nano Lett. 2020;20(11):8141–50.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hu J, Yang L, Yang P, Jiang S, Liu X, Li Y. Polydopamine free radical scavengers. Biomater Sci. 2020;8(18):4940–50.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ruan L, Song G, Zhang X, Liu T, Sun Y, Zhu J, Zeng Z, Jiang G. Transdermal delivery of multifunctional CaO2@Mn-PDA nanoformulations by microneedles for NIR-induced synergistic therapy against skin melanoma. Biomater Sci. 2021;9(20):6830–41.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Shi CX, Dawulieti J, Shi FY, Yang C, Qin Q, Shi TF, Wang LZ, Hu HZ, Sun MD, Ren L, et al. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease. Sci Adv. 2022;8(4):eabj2372.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Doughty ACV, Hoover AR, Layton E, Murray CK, Howard EW, Chen WR. Nanomaterial Applications in Photothermal Therapy for Cancer. Mater (Basel). 2019;12(5):779.

    Article 
    CAS 

    Google Scholar
     

  • Wu Y, Chen F, Huang N, Li J, Wu C, Tan B, Liu Y, Li L, Yang C, Shao D, Liao J. Near-infrared light-responsive hybrid hydrogels for the synergistic chemo-photothermal therapy of oral cancer. Nanoscale. 2021;13(40):17168–82.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang Z, Chang ZM, Shao D, Zhang F, Chen F, Li L, Ge MF, Hu R, Zheng X, Wang Y, Dong WF. Janus Gold Triangle-Mesoporous silica nanoplatforms for hypoxia-activated radio-chemo-photothermal therapy of Liver Cancer. ACS Appl Mater Interfaces. 2019;11(38):34755–65.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jang HJ, Lee SA, Seong S, Kim S, Han G. Combined treatment for lung metastasis from Hepatocellular Carcinoma: a Case Report. Explore-the J Sci Healing. 2018;14(5):385–8.


    Google Scholar
     

  • He MY, Yang T, Wang YH, Wang MY, Chen XY, Ding DW, Zheng YR, Chen HB. Immune Checkpoint inhibitor-based strategies for synergistic Cancer therapy. Adv Healthc Mater. 2021;10(9):2002104.

    Article 
    CAS 

    Google Scholar
     

  • Shen LJ, Zhou TJ, Fan YT, Chang X, Wang Y, Sun JG, Xing L, Jiang HL. Recent progress in tumor photodynamic immunotherapy. Chin Chem Lett. 2020;31(7):1709–16.

    Article 
    CAS 

    Google Scholar
     

  • Li M, Xie D, Tang XF, Yang C, Shen YQ, Zhou H, Deng WX, Liu JW, Cai SB, Bai L, Wang YC. Phototherapy facilitates Tumor Recruitment and activation of natural killer T cells for Potent Cancer Immunotherapy. Nano Lett. 2021;21(14):6304–13.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhang F, Chen F, Yang C, Wang L, Hu H, Li X, Zheng X, Wang Z, Chang Z, Li T, et al. Coordination and Redox Dual-Responsive Mesoporous Organosilica Nanoparticles amplify immunogenic cell death for Cancer Chemoimmunotherapy. Small. 2021;17(26):e2100006.

    Article 
    PubMed 

    Google Scholar